Climb Bio Inc.
CLYM | NASDAQ
$10.24
-$0.09 (-0.87%)
At close: Oct 30, 2026, 3:59 PM ET
$10.25
+$0.01 (+0.10%)
Pre-market:
Nov 2, 2026, 4:36 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 97K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -97K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -67.88M | -82.02M | -40.28M | -45.14M | -35.67M | -20.93M |
Interest Income | 8.32M | 8.13M | 4.62M | 1.38M | n/a | n/a |
Pretax Income | -59.85M | -73.9M | -35.12M | -45.24M | -47.48M | -20.67M |
Net Income | -59.85M | -73.9M | -35.12M | -45.24M | -47.48M | -20.67M |
Selling & General & Admin | 21.17M | 16.03M | 24.86M | 18.92M | 12.35M | 2.43M |
Research & Development | 46.62M | 14.34M | 15.41M | 26.21M | 23.32M | 9.34M |
Other Expenses | n/a | 51.66M | n/a | n/a | n/a | 9.16M |
Operating Expenses | 67.79M | 82.02M | 40.28M | 45.14M | 35.67M | 20.93M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 67.88M | 82.02M | 40.28M | 45.14M | 35.67M | 20.93M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 67.81M | 48.16M | 26.99M | 26.31M | 12.26M | 11.66M |
Shares Outstanding (Diluted) | 67.81M | 48.16M | 26.99M | 26.31M | 12.26M | 11.66M |
EPS (Basic) | -0.88 | -1.53 | -1.30 | -1.72 | -4.24 | -1.97 |
EPS (Diluted) | -0.88 | -1.53 | -1.30 | -1.72 | -4.24 | -1.97 |
EBITDA | -59.75M | -30.36M | -35.12M | -45.24M | -47.48M | -11.77M |
EBIT | -59.85M | -30.36M | -35.12M | -45.24M | -47.48M | -11.77M |
Depreciation & Amortization | 97K | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CLYM